Evidence map›Paper›PMID 30892223›Full record

ArticleIEEE transactions on nanobioscience2019

Structured Hydrogel Particles With Nanofabricated Interfaces via Controlled Oxygen Inhibition.

Daniel Debroy, Jing Liu, Katie Li-Oakey, John Oakey

Open access · greenAbstract read
In one paragraph

Article in IEEE transactions on nanobioscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Microfluidic encapsulation ofSTAR protocols · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Daniel Debroy
Jing Liu
Katie Li-Oakey
John Oakey
University of Wyoming · US

Funding

Wyoming INBRE Phase 4- Equipment Supplement for x-ray diffractometer for Center for Advanced Scientific InstrumentationP20GM103432 · NIGMS · UNIVERSITY OF WYOMING · PI Robert Scott Seville · 2012 to 2026
$56.8M
NIGMS NIH HHS P20 GM103432
6 · The paper itself

Abstract

Hydrogels have been engineered for a variety of biomedical applications, including biosensing, drug delivery, cell delivery, and tissue engineering. The fabrication of hydrogels into nanoscale and microscale particles has been a subject of intense activity and promises to extend their range of applicability. As hydrogels are reduced in size, their interfacial properties represent an increasingly significant contribution to their function and behavior. Hydrogel microparticle-based biosensing and drug delivery platforms, for instance, requires delicate spatial control over the conjugation of biofunctional groups and network architecture, which impacts their mechanical properties and molecular permeability and diffusivity. Here, we demonstrate the ability to tune, with extraordinary precision, the interfacial properties of PEGDA particles generated in a droplet microfluidic device exploiting oxygen-inhibited photopolymerization. We demonstrate the broad utility of these engineered microgels by creating spherical particles with complex but predictable radial crosslinking density gradients. Immunoassays were conducted to examine the network properties of these particles, revealing a high degree of structural tenability, which, in turn, dictates macromolecule encapsulation and release profiles, as well as the presence of radial crosslinking gradients that impact the availability of functional groups.

Indexed as

Lab-On-A-Chip DevicesHydrogelsImmunoglobulin GMyoglobinNanostructuresNanotechnologyOxygenPolyethylene GlycolsHydrogelsImmunoglobulin GMyoglobinOxygenpoly(ethylene glycol)diacrylatePolyethylene Glycols

Identifiers

PMID30892223
PMCPMC6520256
OpenAlexW2921220389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.